Blade Therapeutics

Blade Therapeutics is a biopharmaceutical company focused on developing cutting-edge therapies for fibrotic and neurodegenerative diseases that affect millions of people worldwide. The company's mission is to create antifibrotic treatment strategies to address various congenital and acquired fibrotic conditions. The leadership team has extensive experience in developing drugs for fibrotic diseases. The company also collaborates with international experts to identify and license state-of-the-art technologies, building a robust pipeline of antifibrotic compounds.